Form D · Biotechnology
C16 Biosciences, Inc.
New York, NY · CIK 0001757728
Offering snapshot reported Mar 22, 2023 · SEC filing
- Reported sold
- $4.98M Offering amount: $10.2M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 21, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 22, 2023 | Initial | $4,984,415 | No comparison | 17 | SEC filing |
| Mar 11, 2020 | Amendment | $19,999,994 | $0vs Mar 3, 2020 | 45 | SEC filing |
| Mar 3, 2020 | Initial | $19,999,994 | No comparison | 45 | SEC filing |
| Nov 21, 2018 | Initial | $3,965,000 | No comparison | 33 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-476640
Source: Form D, filed Mar 22, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Heller | Promoter |
| Harold Mc Namara | Director |
| Andrew Shumaker | Director, Promoter |
| Shara Ticku | Director, Executive, Promoter |
| Peter Turner | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
619 W 54th Street, 7th Floor
New York, NY, 10019
New York, NY, 10019